Analytical Data
-
基因名
EPSTI1
- Application
-
别名
EPSTI1；Epithelial-stromal interaction Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96J88
-
表达区间
1-318aa
-
氨基酸序列
MNTRNRVVNS GLGASPASRP TRDPQDPSGR QGELSPVEDQ REGLEAAPKG PSRESVVHAG QRRTSAYTLI APNINRRNEI QRIAEQELAN LEKWKEQNRA KPVHLVPRRL GGSQSETEVR QKQQLQLMQS KYKQKLKREE SVRIKKEAEE AELQKMKAIQ REKSNKLEEK KRLQENLRRE AFREHQQYKT AEFLSKLNTE SPDRSACQSA VCGPQSSTWK LPILPRDHSW ARSWAYRDSL KAEENRKLQK MKDEQHQKSE LLELKRQQQE QERAKIHQTE HRRVNNAFLD RLQGKSQPGG LEQSGGCWNM NSGNSWGI
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EPSTI1, or epithelial serine/threonine kinase 1, is a protein that has garnered interest in biomedical research due to its potential role in cancer biology and cellular signaling pathways. Initially identified as a tumor-associated antigen, EPSTI1 has been found to be overexpressed in various malignancies, indicating its potential as a biomarker for cancer diagnosis and prognosis. Research has shown that EPSTI1 is involved in key cellular processes, including proliferation, apoptosis, and migration, suggesting it may play a pivotal role in tumorigenesis. The recombinant production of EPSTI1 protein provides a valuable tool for studying its structural and functional properties, as well as its interactions with other proteins and cellular components. By generating and characterizing EPSTI1 in a controlled laboratory setting, researchers can explore its mechanisms of action and assess its potential as a therapeutic target. Furthermore, understanding the role of EPSTI1 in the context of cancer progression could pave the way for novel treatment strategies, as therapies aimed at modulating its activity may enhance the effectiveness of existing cancer treatments or provide new avenues for intervention. Overall, the study of recombinant EPSTI1 protein is an important step towards elucidating its biological significance and potential applications in cancer therapy.
